AAAAAA

   
Results: 1-16 |
Results: 16
HERPETIC WHITLOW OF THE TOE - AN UNUSUAL MANIFESTATION OF INFECTION WITH HERPES-SIMPLEX VIRUS TYPE-2
Authors: EGAN LJ BYLANDER JM AGERTER DC EDSON RS
Citation: Lj. Egan et al., HERPETIC WHITLOW OF THE TOE - AN UNUSUAL MANIFESTATION OF INFECTION WITH HERPES-SIMPLEX VIRUS TYPE-2, Clinical infectious diseases, 26(1), 1998, pp. 196-197
DIALYSIS OF THE RECTUM FOR SAMPLING DRUG CONCENTRATIONS IN THE LUMINAL EXTRACELLULAR FLUID OF THE GUT - TECHNIQUE AND PRECISION
Authors: EGAN LJ SANDBORN WJ MAYS DC TREMAINE WJ LIPSKY JJ
Citation: Lj. Egan et al., DIALYSIS OF THE RECTUM FOR SAMPLING DRUG CONCENTRATIONS IN THE LUMINAL EXTRACELLULAR FLUID OF THE GUT - TECHNIQUE AND PRECISION, Alimentary pharmacology & therapeutics, 12(7), 1998, pp. 679-684
DRUG-THERAPY OF INFLAMMATORY BOWEL-DISEASE
Authors: EGAN LJ SANDBORN WJ
Citation: Lj. Egan et Wj. Sandborn, DRUG-THERAPY OF INFLAMMATORY BOWEL-DISEASE, Medicamentos de actualidad, 34(5), 1998, pp. 431-446
A RANDOMIZED, SINGLE-BLIND, PHARMACOKINETIC AND DOSERESPONSE STUDY OFSUBCUTANEOUS METHOTREXATE, 15 AND 25 MG WEEK, FOR REFRACTORY ULCERATIVE-COLITIS AND CROHNS-DISEASE/
Authors: EGAN LJ SANDBORN WJ TREMAINE WJ LEIGHTON JA MAYS DC PIKE MG ZINSMEISTER AR LIPSKY JJ
Citation: Lj. Egan et al., A RANDOMIZED, SINGLE-BLIND, PHARMACOKINETIC AND DOSERESPONSE STUDY OFSUBCUTANEOUS METHOTREXATE, 15 AND 25 MG WEEK, FOR REFRACTORY ULCERATIVE-COLITIS AND CROHNS-DISEASE/, Gastroenterology, 114(4), 1998, pp. 3978-3978
DIALYSIS OF THE RECTUM FOR SAMPLING OF EXOGENOUS MOLECULE, METHOTREXATE AND AN ENDOGENOUS MOLECULE, POTASSIUM - TECHNIQUE AND VALIDATION
Authors: EGAN LJ SANDBORN WJ MAYS DC TREMAINE WJ LIPSKY JJ
Citation: Lj. Egan et al., DIALYSIS OF THE RECTUM FOR SAMPLING OF EXOGENOUS MOLECULE, METHOTREXATE AND AN ENDOGENOUS MOLECULE, POTASSIUM - TECHNIQUE AND VALIDATION, Gastroenterology, 114(4), 1998, pp. 3979-3979
INTESTINAL LUMEN AND TISSUE PHARMACOKINETICS OF METHOTREXATE IN INFLAMMATORY BOWEL-DISEASE - SUBCUTANEOUS METHOTREXATE ACHIEVES PHARMACOLOGICALLY ACTIVE CONCENTRATIONS IN THE RECTUM
Authors: EGAN LJ SANDBORN WJ MAYS DC TREMAINE WJ LIPSKY JJ
Citation: Lj. Egan et al., INTESTINAL LUMEN AND TISSUE PHARMACOKINETICS OF METHOTREXATE IN INFLAMMATORY BOWEL-DISEASE - SUBCUTANEOUS METHOTREXATE ACHIEVES PHARMACOLOGICALLY ACTIVE CONCENTRATIONS IN THE RECTUM, Gastroenterology, 114(4), 1998, pp. 3980-3980
IS THE ANTIINFLAMMATORY ACTION OF METHOTREXATE MEDIATED BY ADENOSINE
Authors: EGAN LJ SANDBORN WJ MAYS DC TREMAINE WJ LIPSKY JJ
Citation: Lj. Egan et al., IS THE ANTIINFLAMMATORY ACTION OF METHOTREXATE MEDIATED BY ADENOSINE, Gastroenterology, 114(4), 1998, pp. 3981-3981
RECTAL PHARMACOKINETICS OF METHOTREXATE IN INFLAMMATORY BOWEL-DISEASE
Authors: EGAN LJ SANDBORN WJ MAYS DC TREMAINE WJ LIPSKY JJ
Citation: Lj. Egan et al., RECTAL PHARMACOKINETICS OF METHOTREXATE IN INFLAMMATORY BOWEL-DISEASE, Clinical pharmacology and therapeutics, 63(2), 1998, p.
CLINICAL OUTCOME FOLLOWING TREATMENT OF REFRACTORY INFLAMMATORY AND FISTULIZING CROHNS-DISEASE WITH INTRAVENOUS CYCLOSPORINE
Authors: EGAN LJ SANDBORN WJ TREMAINE WJ
Citation: Lj. Egan et al., CLINICAL OUTCOME FOLLOWING TREATMENT OF REFRACTORY INFLAMMATORY AND FISTULIZING CROHNS-DISEASE WITH INTRAVENOUS CYCLOSPORINE, The American journal of gastroenterology, 93(3), 1998, pp. 442-448
OUTCOME OF INTRAVENOUS (IV) FOLLOWED BY ORAL CYCLOSPORINE (CYA) FOR REFRACTORY CROHNS-DISEASE (CD)
Authors: EGAN LJ SANDBORN WJ TREMAINE WJ
Citation: Lj. Egan et al., OUTCOME OF INTRAVENOUS (IV) FOLLOWED BY ORAL CYCLOSPORINE (CYA) FOR REFRACTORY CROHNS-DISEASE (CD), Gastroenterology, 112(4), 1997, pp. 964-964
CELIAC-DISEASE AND T-CELL LYMPHOMA
Authors: EGAN LJ STEVENS FM MCCARTHY CF
Citation: Lj. Egan et al., CELIAC-DISEASE AND T-CELL LYMPHOMA, The New England journal of medicine, 335(21), 1996, pp. 1611-1612
METHOTREXATE FOR INFLAMMATORY BOWEL-DISEASE - PHARMACOLOGY AND PRELIMINARY-RESULTS
Authors: EGAN LJ SANDBORN WJ
Citation: Lj. Egan et Wj. Sandborn, METHOTREXATE FOR INFLAMMATORY BOWEL-DISEASE - PHARMACOLOGY AND PRELIMINARY-RESULTS, Mayo Clinic proceedings, 71(1), 1996, pp. 69-80
ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA IN THE WEST OF IRELAND - LOW-FREQUENCY OF EPSTEIN-BARR-VIRUS IN THESE TUMORS
Authors: WALSH SV EGAN LJ CONNOLLY CE STEVENS FM EGAN EL MCCARTHY CF
Citation: Sv. Walsh et al., ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA IN THE WEST OF IRELAND - LOW-FREQUENCY OF EPSTEIN-BARR-VIRUS IN THESE TUMORS, Modern pathology, 8(7), 1995, pp. 753-757
CELIAC-ASSOCIATED LYMPHOMA - A SINGLE INSTITUTION EXPERIENCE OF 30 CASES IN THE COMBINATION CHEMOTHERAPY ERA
Authors: EGAN LJ WALSH SV STEVENS FM CONNOLLY CE EGAN EL MCCARTHY CF
Citation: Lj. Egan et al., CELIAC-ASSOCIATED LYMPHOMA - A SINGLE INSTITUTION EXPERIENCE OF 30 CASES IN THE COMBINATION CHEMOTHERAPY ERA, Journal of clinical gastroenterology, 21(2), 1995, pp. 123-129
ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA (EATL) IN THE WEST OF IRELAND - LOW-FREQUENCY OF EPSTEIN-BARR-VIRUS IN THESE TUMORS
Authors: WALSH SV EGAN LJ MCCARTHY CF CONNOLLY CE
Citation: Sv. Walsh et al., ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA (EATL) IN THE WEST OF IRELAND - LOW-FREQUENCY OF EPSTEIN-BARR-VIRUS IN THESE TUMORS, Laboratory investigation, 72(1), 1995, pp. 70-70
HEREDITARY-DEFICIENCY OF THE 7TH COMPONENT OF COMPLEMENT AND RECURRENT MENINGOCOCCAL INFECTION - INVESTIGATIONS OF AN IRISH FAMILY USING A NOVEL HEMOLYTIC SCREENING ASSAY FOR COMPLEMENT ACTIVITY AND C7 M N ALLOTYPING/
Authors: EGAN LJ ORREN A DOHERTY J WURZNER R MCCARTHY CF
Citation: Lj. Egan et al., HEREDITARY-DEFICIENCY OF THE 7TH COMPONENT OF COMPLEMENT AND RECURRENT MENINGOCOCCAL INFECTION - INVESTIGATIONS OF AN IRISH FAMILY USING A NOVEL HEMOLYTIC SCREENING ASSAY FOR COMPLEMENT ACTIVITY AND C7 M N ALLOTYPING/, Epidemiology and infection, 113(2), 1994, pp. 275-281
Risultati: 1-16 |